Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
101.99
Dollar change
-0.53
Percentage change
-0.52
%
Index- P/E11.90 EPS (ttm)8.57 Insider Own0.00% Shs Outstand2.00B Perf Week-3.57%
Market Cap199.54B Forward P/E12.42 EPS next Y8.21 Insider Trans- Shs Float1.96B Perf Month-4.51%
Income17.60B PEG1.68 EPS next Q1.83 Inst Own6.77% Short Float0.24% Perf Quarter-12.95%
Sales48.59B P/S4.11 EPS this Y17.13% Inst Trans-0.46% Short Ratio4.22 Perf Half Y-3.17%
Book/sh21.67 P/B4.71 EPS next Y8.36% ROA10.88% Short Interest4.79M Perf Year5.09%
Cash/sh7.17 P/C14.23 EPS next 5Y7.07% ROE28.87% 52W Range92.35 - 120.92 Perf YTD1.01%
Dividend Est.3.78 (3.71%) P/FCF13.52 EPS past 5Y5.63% ROI25.64% 52W High-15.65% Beta0.56
Dividend TTM3.74 (3.67%) Quick Ratio0.90 Sales past 5Y0.78% Gross Margin73.83% 52W Low10.44% ATR (14)1.34
Dividend Ex-DateMar 07, 2024 Current Ratio1.11 EPS Y/Y TTM130.88% Oper. Margin29.63% RSI (14)33.04 Volatility0.80% 0.85%
Employees76057 Debt/Eq0.74 Sales Y/Y TTM-4.82% Profit Margin36.23% Recom2.82 Target Price116.12
Option/ShortYes / Yes LT Debt/Eq0.59 EPS Q/Q85.38% Payout44.73% Rel Volume0.71 Prev Close102.52
Sales Surprise0.24% EPS Surprise6.27% Sales Q/Q8.84% EarningsOct 29 BMO Avg Volume1.14M Price101.99
SMA20-1.87% SMA50-6.97% SMA200-4.32% Trades Volume801,662 Change-0.52%
Date Action Analyst Rating Change Price Target Change
Dec-04-24Downgrade HSBC Securities Hold → Reduce
Sep-11-24Downgrade BofA Securities Buy → Neutral $135 → $130
Sep-05-24Downgrade Goldman Buy → Neutral
Sep-03-24Downgrade Jefferies Buy → Hold
Jul-19-24Downgrade Deutsche Bank Buy → Hold
May-30-24Initiated Goldman Buy $120
Feb-23-24Initiated BMO Capital Markets Market Perform $114
Jan-23-24Initiated Morgan Stanley Equal-Weight $114
Jan-16-24Resumed UBS Buy
Dec-18-23Downgrade HSBC Securities Buy → Hold
Dec-08-24 12:30PM
Dec-06-24 01:15AM
Dec-04-24 09:45AM
07:15AM
Dec-03-24 09:17AM
04:42AM Loading…
04:42AM
Dec-02-24 04:21PM
12:58PM
12:40PM
11:29AM
07:47AM
07:00AM
05:56AM
Dec-01-24 03:45PM
Nov-30-24 07:05PM
04:17PM Loading…
04:17PM
Nov-27-24 10:25AM
01:15AM
Nov-26-24 06:55AM
Nov-25-24 01:15AM
Nov-23-24 10:24AM
Nov-22-24 06:41AM
04:09AM
Nov-21-24 10:17AM
06:50AM
06:48AM
01:00AM
Nov-19-24 08:00AM
07:45AM
06:35AM
08:00AM Loading…
Nov-18-24 08:00AM
12:44AM
Nov-15-24 12:40PM
09:40AM
08:46AM
Nov-14-24 09:35AM
Nov-13-24 09:55AM
09:35AM
08:37AM
06:56AM
06:15AM
03:28AM
02:06AM
12:54AM
Nov-12-24 11:06AM
Nov-08-24 09:36AM
Nov-05-24 09:40AM
07:05AM
Nov-02-24 05:38AM
Oct-30-24 03:12PM
09:40AM
07:46AM
06:48AM
03:07AM
Oct-29-24 07:54PM
04:11PM
03:03PM
02:15PM
01:00PM
11:50AM
10:57AM
09:34AM
09:30AM
08:52AM
07:39AM
07:39AM
07:09AM
07:08AM
06:58AM
05:54AM
05:07AM
02:00AM
Oct-28-24 05:40PM
02:26PM
02:10PM
08:53AM
08:46AM
07:33AM
06:19AM
Oct-26-24 07:50PM
Oct-24-24 09:15AM
08:15AM
01:15AM
Oct-21-24 09:00AM
Oct-18-24 01:37PM
07:04AM
06:53AM
Oct-17-24 08:45AM
Oct-15-24 12:00PM
07:32AM
Oct-14-24 09:45AM
Oct-10-24 11:58PM
09:50AM
Oct-09-24 04:47PM
Oct-05-24 06:30PM
Oct-03-24 08:30AM
Oct-01-24 02:51PM
Sep-27-24 09:15AM
Sep-26-24 08:40AM
Sep-25-24 01:15PM
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kowalski Robert WilliamOfficerAug 12 '24Proposed Sale111.726,566733,572Aug 12 03:30 PM